SCHEMBL8865183

SCHEMBL8865183

CNC(=S)NC=O.COc1ccc(C2C(N=S(=O)=O)C2(C)C)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ PKM P14618 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ P2RX2 Q9UBL9 1/20 0.31
▸ MAPT P10636 1/20 0.30
▸ ALOX12 P18054 1/20 0.30
▸ PLK1 P53350 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8864447 0.88 PLK1 (0.33) HPGDLMNAKDM4ECYP2C9CYP2C19
SCHEMBL8864569 0.86 HPGD (0.34) HPGDTDP1LMNAKDM4ECYP2C9
SCHEMBL8864541 0.75 HPGD (0.34) HPGDTDP1LMNAKDM4ECYP2C9
SCHEMBL8864420 0.74 ALDH1A1 (0.32) HPGDLMNAKDM4ECYP2C9CYP2C19
SCHEMBL8864941 0.72 TDP1 (0.33) HPGDTDP1LMNAKDM4EP2RX2
SCHEMBL8864591 0.63 MAPT (0.32) CYP2C9CYP2C19PKMCYP1A2CYP3A4
SCHEMBL6326547 0.61 ALDH1A1 (0.42) HPGDKDM4EALDH1A1MAPTNPC1
SCHEMBL6317160 0.57 EDNRA (0.47) HPGDLMNAKDM4EALDH1A1MAPT
SCHEMBL6317044 0.57 EDNRA (0.47) HPGDLMNAKDM4EALDH1A1MAPT
SCHEMBL6317175 0.57 EDNRA (0.47) HPGDLMNAKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5633239-A CARDIOVASCULAR DISORDERS; HYPOGLYCEMIC AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-27 — — US disclosed
Send feedback